“`html
Isomorphic Labs: Pioneering AI-Driven Drug Discovery
Founded in 2021 as a subsidiary of deepmind (itself a part of Alphabet, Google’s parent company), Isomorphic Labs is revolutionizing drug discovery. The company aims to commercialize AlphaFold,the groundbreaking technology that predicts protein structures with remarkable accuracy,adn apply it to the development of novel therapeutics.
Leadership and Partnerships
Isomorphic Labs is led by Demis Hassabis, who, along with John Jumper, received the 2024 Nobel Prize in Chemistry for thier work on AI-based protein








